- Homepage release
Creating a new drug discovery platform, connecting Japan and Asia
EPS Innovative Medicine interfaces between discovery research of new seeds by academia /bio-venture companies and markets by facilitating early launch of potential drugs.
EPS Innovative Medicine is engaged in discovery and development of a set of various drug candidates in pipeline to be launched into Asian and other overseas markets.
globally oriented company
EPS Innovative Medicine is the first drug discovery company established to mark the 30th anniversary of EPS, a leading Japan-based contract research organization (CRO).
Please feel free to contact us.